Operating Lease, Liability of ELITE PHARMACEUTICALS INC /NV/ from 02 Apr 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Operating Lease, Liability in USD history and change rate from 02 Apr 2019 to 31 Dec 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Operating Lease, Liability for the quarter ending 31 Dec 2025 was $1,676,900, a 21% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,676,900 -$457,397 -21% 31 Dec 2025 10-Q 17 Feb 2026 2026 Q3
Q3 2025 $1,796,473 -$367,090 -17% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 $1,911,879 -$355,544 -16% 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q1 2025 $2,024,465 -$344,342 -15% 31 Mar 2025 10-K 30 Jun 2025 2025 FY
Q4 2024 $2,134,297 +$2,108,067 +8037% 31 Dec 2024 10-Q 13 Feb 2025 2025 Q3
Q3 2024 $2,163,563 +$2,161,400 +99926% 30 Sep 2024 10-Q 14 Nov 2024 2025 Q2
Q2 2024 $2,267,423 +$2,258,837 +26308% 30 Jun 2024 10-Q 14 Aug 2024 2025 Q1
Q1 2024 $2,368,807 +$2,366,644 +109415% 31 Mar 2024 10-K 01 Jul 2024 2024 FY
Q4 2023 $26,230 +$5,081 +24% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 $2,163 -$25,065 -92% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q2
Q2 2023 $8,586 -$981,019 -99% 30 Jun 2023 10-Q 14 Aug 2023 2024 Q1
Q1 2023 $2,163 -$1,036,683 -100% 31 Mar 2023 10-Q 14 Nov 2023 2024 Q2
Q4 2022 $21,149 -$1,066,206 -98% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 $27,228 -$1,122,086 -98% 30 Sep 2022 10-Q 14 Nov 2022 2023 Q2
Q2 2022 $989,605 -$220,380 -18% 30 Jun 2022 10-Q 15 Aug 2022 2023 Q1
Q1 2022 $1,038,846 +$811,890 +358% 31 Mar 2022 10-K 29 Jun 2022 2022 FY
Q4 2021 $1,087,355 +$866,189 +392% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q3
Q3 2021 $1,149,314 +$876,002 +321% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q2
Q2 2021 $1,209,985 $0 0% 30 Jun 2021 10-Q 16 Aug 2021 2022 Q1
Q1 2021 $226,956 -$148,337 -40% 31 Mar 2021 10-K 14 Jun 2021 2021 FY
Q4 2020 $221,166 -$203,984 -48% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 $273,312 -$199,868 -42% 30 Sep 2020 10-Q 16 Nov 2020 2021 Q2
Q2 2020 $1,209,985 +$689,489 +132% 30 Jun 2020 10-Q 16 Aug 2021 2022 Q1
Q1 2020 $375,293 -$224,707 -37% 31 Mar 2020 10-K 29 Jun 2020 2020 FY
Q4 2019 $425,150 31 Dec 2019 10-Q 10 Feb 2020 2020 Q3
Q3 2019 $473,180 30 Sep 2019 10-Q 12 Nov 2019 2020 Q2
Q2 2019 $520,496 30 Jun 2019 10-Q 09 Aug 2019 2020 Q1
Q1 2019 $600,000 02 Apr 2019 10-K 29 Jun 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.